Endoscopic therapy in advanced central type lung cancer
Sekiguchi, N.
Panminerva Medica 28(4): 313-320
1986
ISSN/ISBN: 0031-0808 PMID: 2437514 Document Number: 279753
Document emailed within 1 workday
Related Documents
Takahashi, E.; Koshiishi, H.; Sakaniwa, N.; Okunaka, T.; Takei, H.; Hayashi, N.; Takahashi, M.; Ikeda, N. 2014: Photodynamic therapy for multiple central type lung cancer - a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 2042-2043Ishii, N.; Fujitani, S.; Suzuki, S.; Tsukamoto, M.; Arai, M.; Hashimoto, A.; Izuka, Y.; Fukuda, K.; Horiki, N.; Fujita, Y. 2008: A case of advanced gastric cancer with pyloric stenosis and obstructive jaundice responding to s-1/paclitaxel combination therapy after endoscopic balloon dilatation and endoscopic biliary drainage Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 121-124
Ying Geng, Z.; Chang Jiao, S.; Cui Liu, S.; Li, Y.; Feng Liu, Z.; Qing Zhang, G.; Jie Wang, L.; Qu, F. 2013: Third-line therapy in advanced non-small cell lung cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 18(4): 899-907
Nakamura, Y.; Yamamoto, N. 2009: Second-line treatment and targeted therapy of advanced lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 710-716
Hashizume, T.; Ogura, T.; Kozawa, S.; Kobayashi, N.; Tagawa, A.; Miyazawa, N.; Watanuki, Y.; Takahashi, H. 2006: Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 467-470
Furuichi, M.; Muramatsu, T.; Shimamura, M.; Nishii, T.; Takeshita, S.; Ishimoto, S.; Morooka, H.; Sodeyama, M.; Sakurai, K.; Amano, S.; Ohmori, I.; Shiono, M. 2010: Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 119-122
Li, F.; Chen, G.; Jiao, S. 2015: Bevacizumab Combined with Chemotherapy as First-line Therapy for Advanced Non-Small Cell Lung Cancer: A Retrospective Study Hepato-Gastroenterology 62(140): 797-801
Morihata, K.; Kimura, M.; Okada, K.; Usami, E.; Nakao, T.; Yoshimura, T.; Hayase, K.; Yasuda, T. 2010: Comparative safety evaluation of first- and second-line therapy with carboplatin + paclitaxel for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 45-50
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Zhang, X.; Sun, Y.; Kong, W. 1998: Navelbine plus cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 42 cases Zhonghua Zhong Liu Za Zhi 20(1): 60-62
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
Shimizu, M.; Miya, T.; Takahashi, A.; Kobayashi, Y.; Kubota, K.; Gemma, A.; Hirose, T. 2017: Nearly Complete Response after Second-Line Therapy with Nab-Paclitaxel Monotherapy in a Patient with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(8): 699-702
Fujita, A.; Igami, Y.; Takabatake, H.; Tagaki, S.; Yamamoto, R.; Sekine, K. 1999: Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 805-811
Hirai, F. 2015: III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
Khuri, F.R. 2002: Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy Oncology 16(6 Suppl 6: 53-62
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Socinski, M.A.; Langer, C.J. 1999: Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer Seminars in Oncology 26(5 Suppl 16: 51-61; Discussion: 71-72
Kimura, I.; Ohnoshi, T.; Nakata, Y.; Nakata, Y.; Hiraki, S.; Miyake, K. 1980: Lung cancer: problems in the treatment of advanced lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 18(9): 572-577
Tanemura, H.; Oshita, H.; Kanno, A.; Kusakabe, M.; Hatoh, T.; Yamada, M.; Adachi, T.; Nishio, K.; Saito, S.; Tomita, E.; Sugiyama, A.; Yamada, T. 2005: Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(13): 2079-2085